EAU 2017: State-of-the-art Lecture: How will Immunotherapy Change the Treatment Paradigm? – UroToday
|
EAU 2017: State-of-the-art Lecture: How will Immunotherapy Change the Treatment Paradigm?
UroToday Dr. Jones concluded this thought provoking session by noting that immunotherapy is here to stay as second line treatment and we urgently need to understand patient selection in the first line setting. Ultimately, we need careful research to “harness … |
